Stephen C. Pak

Stephen C. Pak

Auto-generated profile, based on publicly available information

Stephen C. Pak

Department of Pediatrics, Washington University School of Medicine, St Louis, MO 63110, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
QSQingya Shi
Qingya Shi
FPFen Pei
Fen Pei
GSGary A. Silverman
Gary A. Silverman
SPStephen C. Pak
Stephen C. Pak
DPDavid H. Perlmutter
David H. Perlmutter
IBIvet Bahar
Ivet Bahar
Autophagy plays an essential role in cell survival/death and functioning. Modulation of autophagy has been recognized as a promising therapeutic strategy against diseases/disorders associated with uncontrolled growth or accumulation of biomolecular aggregates, organelles, or cells including those caused by cancer, aging, neurodegeneration, and liver diseases such as α1-antitrypsin deficiency. Numerous pharmacological agents that enhance or suppress autophagy have been discovered. However, their molecular mechanisms of action are far from clear. Here, we collected a set of 225 autophagy modulators and carried out a comprehensive quantitative systems pharmacology (QSP) analysis of their targets using both existing databases and predictions made by our machine learning algorithm. Autophagy modulators include several highly promiscuous drugs (e.g., artenimol and olanzapine acting as activators, fostamatinib as an inhibitor, or melatonin as a dual-modulator) as well as selected drugs that uniquely target specific proteins (~30% of modulators). They are mediated by three layers of regulation: (i) pathways involving core autophagy-related (ATG) proteins such as mTOR, AKT, and AMPK; (ii) upstream signaling events that regulate the activity of ATG pathways such as calcium-, cAMP-, and MAPK-signaling pathways; and (iii) transcription factors regulating the expression of ATG proteins such as TFEB, TFE3, HIF-1, FoxO, and NF-κB. Our results suggest that PKA serves as a linker, bridging various signal transduction events and autophagy. These new insights contribute to a better assessment of the mechanism of action of autophagy modulators as well as their side effects, development of novel polypharmacological strategies, and identification of drug repurposing opportunities.

4 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
HHHuiyan Huang
Huiyan Huang
JPJiehong Pan
Jiehong Pan
DSDavid R. Spielberg
David R. Spielberg
NHNeil A. Hanchard
Neil A. Hanchard
DSDaryl A. Scott
Daryl A. Scott
TSTim Schedl
Tim Schedl
Significance: The Rab5 GTPase functions in early endosome (EE) fusion in the endocytic pathway. Here, we propose that RAB5B also has a noncanonical vesicular fusion function in the regulated secretion pathway that produces mature surfactant proteins SP-B and SP-C in the lung. This function was revealed from investigation of a proband with interstitial lung disease suggestive of a surfactant dysfunction disorder who carried a de novo Asp136His variant in the RAB5B gene. Our modeling in C. elegans provided information on the genetic and cell biological mechanism, and analyses of proband and normal lung biopsies suggested a function for RAB5B and EEs in surfactant protein processing/trafficking. This work indicates that RAB5B p.Asp136His causes a surfactant dysfunction disorder.

12 January 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
CLCliff J. Luke
Cliff J. Luke
SMStephanie Markovina
Stephanie Markovina
MGMisty Good
Misty Good
IWIra E. Wight
Ira E. Wight
BTBrian J. Thomas
Brian J. Thomas
GSGary A. Silverman
Gary A. Silverman
Lysosomal membrane permeabilization (LMP) and cathepsin release typifies lysosome-dependent cell death (LDCD). However, LMP occurs in most regulated cell death programs suggesting LDCD is not an independent cell death pathway, but is conscripted to facilitate the final cellular demise by other cell death routines. Previously, we demonstrated that Caenorhabditis elegans (C. elegans) null for a cysteine protease inhibitor, srp-6, undergo a specific LDCD pathway characterized by LMP and cathepsin-dependent cytoplasmic proteolysis. We designated this cell death routine, lysoptosis, to distinguish it from other pathways employing LMP. In this study, mouse and human epithelial cells lacking srp-6 homologues, mSerpinb3a and SERPINB3, respectively, demonstrated a lysoptosis phenotype distinct from other cell death pathways. Like in C. elegans, this pathway depended on LMP and released cathepsins, predominantly cathepsin L. These studies suggested that lysoptosis is an evolutionarily-conserved eukaryotic LDCD that predominates in the absence of neutralizing endogenous inhibitors.

8 December 2023 in Nature Aging
Verified
Journal Article
Closed access
PDF file
SLSeong-won Lee
Seong-won Lee
YOYoung Mi Oh
Young Mi Oh
MVMatheus B. Victor
Matheus B. Victor
YYYan Yang
Yan Yang
SCShawei Chen
Shawei Chen
AYAndrew S. Yoo
Andrew S. Yoo

1 November 2024 in Science
Verified
Journal Article
Closed access
FKFlorian Kraft
Florian Kraft
PRPiere Rodriguez-Aliaga
Piere Rodriguez-Aliaga
WYWeimin Yuan
Weimin Yuan
LFLena Franken
Lena Franken
KZKamil Zajt
Kamil Zajt
IKIngo Kurth
Ingo Kurth
Malformations of the brain are common and vary in severity, from negligible to potentially fatal. Their causes have not been fully elucidated. Here, we report pathogenic variants in the core protein-folding machinery TRiC/CCT in individuals with brain malformations, intellectual disability, and seizures. The chaperonin TRiC is an obligate hetero-oligomer, and we identify variants in seven of its eight subunits, all of which impair function or assembly through different mechanisms. Transcriptome and proteome analyses of patient-derived fibroblasts demonstrate the various consequences of TRiC impairment. The results reveal an unexpected and potentially widespread role for protein folding in the development of the central nervous system and define a disease spectrum of “TRiCopathies.”

12 January 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
SWSongyan Wang
Songyan Wang
CLCliff J. Luke
Cliff J. Luke
SPStephen C. Pak
Stephen C. Pak
VSVictoria Shi
Victoria Shi
LCLiyun Chen
Liyun Chen
SMStephanie Markovina
Stephanie Markovina
The endogenous lysosomal cysteine protease inhibitor SERPINB3 (squamous cell carcinoma antigen 1, SCCA1) is elevated in patients with cervical cancer and other malignancies. High serum SERPINB3 is prognostic for recurrence and death following chemoradiation therapy. Cervical cancer cells genetically lacking SERPINB3 are more sensitive to ionizing radiation (IR), suggesting this protease inhibitor plays a role in therapeutic response. Here we demonstrate that SERPINB3-deficient cells have enhanced sensitivity to IR-induced cell death. Knock out of SERPINB3 sensitizes cells to a greater extent than cisplatin, the current standard of care. IR in SERPINB3 deficient cervical carcinoma cells induces predominantly necrotic cell death, with biochemical and cellular features of lysoptosis. Rescue with wild-type SERPINB3 or a reactive site loop mutant indicates that protease inhibitory activity is required to protect cervical tumor cells from radiation-induced death. Transcriptomics analysis of primary cervix tumor samples and genetic knock out demonstrates a role for the lysosomal protease cathepsin L in radiation-induced cell death in SERPINB3 knock-out cells. These data support targeting of SERPINB3 and lysoptosis to treat radioresistant cervical cancers.